Naphazoline Hydrochloride Ophthalmic Solution is indicated for use as a topical ocular vasoconstrictor.

Contraindicated in the presence of an anatomically narrow angle or in narrow angle glaucoma or in persons who have shown hypersensitivity to any component of this preparation.

---

Angle Closure Glaucoma -- A form of glaucoma in which the intraocular pressure increases because the angle of the anterior chamber is blocked and the aqueous humor cannot drain from the anterior chamber.

Hypersensitivity -- Altered reactivity to an antigen, which can result in pathologic reactions upon subsequent exposure to that particular antigen.

NOT FOR INJECTION INTO THE EYE - FOR TOPICAL USE ONLY.Patients under therapy with MAO inhibitors may experience a severe hypertensive crisis if given a sympathomimetic drug.

Use in pediatric patients, especially infants, may result in CNS depression leading to coma and marked reduction in body temperature.

The following US Branded drugs contain Naphazoline Hydrochloride

---

VASOCON-A -- NOVARTIS PHARMACEUTICALS CORP

ALBALON -- ALLERGAN INC

NAFAZAIR -- BAUSCH AND LOMB PHARMACEUTICALS INC

NAFAZAIR -- PHARMAFAIR INC

NAPHCON FORTE -- ALCON LABORATORIES INC

OPCON -- BAUSCH AND LOMB PHARMACEUTICALS INC

VASOCON -- NOVARTIS PHARMACEUTICALS CORP

NAPHCON-A -- ALCON LABORATORIES INC

OPCON-A -- BAUSCH AND LOMB INC

VISINE-A -- JOHNSON AND JOHNSON GROUP CONSUMER COMPANIES